ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension

Internal Medicine

Volumn 43, Issue 6, 2004, Pages 496-502

  Tomioka, Mai ^a   Hinoshita, Fumihiko ^a   Miyauchi, Naoko ^a   Akiyama, Yurika ^a   Saima, Shigeki ^a   Hiroe, Michiaki ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

ANCA; Crescentic glomerulonephritis; Pulse therapy; Renal crisis; Systemic sclerosis sine scleroderma

Indexed keywords

CANDESARTAN; DIPYRIDAMOLE; HEPARIN; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NIFEDIPINE; PREDNISOLONE; RENIN;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BORDERLINE HYPERTENSION; CASE REPORT; COMORBIDITY; DRUG PULSE THERAPY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; MALIGNANT HYPERTENSION; PLASMA RENIN ACTIVITY; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SCLERODERMA; SKIN MANIFESTATION;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE; MIDDLE AGED; PREDNISOLONE; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 3242752004     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.496     Document Type: Article

References (34)

1. Traub YM, Shapiro AP, Rodnan GP, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis: Review of a 25-year experience with 68 cases. Medicine (Baltimore) 62: 335-352, 1983.
2. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic antibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21: 864-870, 1994.
3. Leroy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202-205, 1998.
4. Poormoghim H, Lucas M, Fertig N, Medsger TA Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 43: 444-451, 2000.
5. Molina JF, Anaya JM, Cabrera GE, Hoffman E, Espinoza LR. Systemic sclerosis sine scleroderma: An unusual presentation in scleroderma renal crisis. J Rheumatol 22: 557-560, 1995.
6. Korzets Z, Schneider M, Savin H, et al. Intriguing presentation of scleroderma renal crisis (scleroderma renal crisis sine scleroderma sine hypertension). Nephrol Dial Transplant 13: 2953-2956, 1998.
7. Phan TG, Cass A, Gillin A, Trew P, Fertig N, Sturgess A. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma. J Rheumatol 26: 2489-2492, 1999.
8. Canet JJ, Castane J, Alvarez M, Nava JM, Llibre J. Scleroderma renal crisis sine scleroderma. Nephron 90: 119-120, 2002.
9. Zwettler U, Andrassy K, Waldherr R, Ritz E. Scleroderma renal crisis as a presenting feature in the absence of skin involvement. Am J Kidney Dis 22: 53-56, 1993.
10. Sanders PW, Herrera GA, Ball GV. Acute renal failure without fibrotic skin changes in progressive systemic sclerosis. Nephron 48: 121-125, 1988.
11. Gouge SF, Wilder K, Welch P, Sabnis SG, Antonovich T. Scleroderma renal crisis prior to scleroderma. Am J Kidney Dis 14: 236-238, 1989.
12. Kapur A, Ballou SP, Renston JP, Luna E, Chung-Park M. Recurrent acute scleroderma renal crisis complicated by thrombotic thrombocytopenic purpura. J Rheumatol 24: 2469-2472, 1997.
13. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34, N Engl J Med 299: 466-474, 1978.
14. Endo H. Scleroderma renal crisis (SRC): hypertensive, normotensive. Nihon Rinsho Meneki Gakkai Kaishi (Jpn J Clin Immunol) 23: 656-660, 2000 (in Japanese).
15. Helfrich DJ, Banner B, Steen VD, Medsger TA Jr. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32: 1128-1134, 1989.
16. Steen VD, Constantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113: 352-357, 1990.
17. Moore HC, Sheehan HL. The kidney of scleroderma. Lancet 259: 68-70, 1952.
18. Calvert RJ, Owen TK. True scleroderma kidney. Lancet 268: 19-22, 1956.
19. Rodnan GP, Schreiner GE, Black RL. Renal involvement in progressive systemic sclerosis (generalized scleroderma). Am J Med 23: 445-462, 1957.
20. Levine RJ, Boshell BR. Renal involvement in progressive systemic sclerosis (scleroderma). Ann Intern Med 52: 517-529, 1960.
21. Salyer WR, Salyer DC, Hepstinstall RH. Scleroderma and microangiopathic hemolytic anemia. Ann Intern Med 78: 895-897, 1973.
22. Cannon PJ, Hassar M, Cane DB, Casarella WJ, Sommers SC, Leroy EC. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 53: 1-46, 1974.
23. Johnson SJ, Spiera H. Development of scleroderma renal failure without severe hypertension. Five cases (abstract). Arthritis Rheum 23: 698, 1980.
24. Kagan A, Nissim F, Green L, Bar-Khayim Y. Scleroderma renal crisis without hypertension. J Rheumatol 16: 707-708, 1989.
25. Huong DL, Papo T, Gatfosse M, Frances C, Godeau P, Beaufils H. Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure. J Rheumatol 22: 791-792, 1995.
26. Omote A, Muramatsu M, Sugimoto Y, et al. MPO-ANCA-related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 36: 508-513, 1997.
27. Hillis GS, Khan IH, Simpson JG, Rees AJ. Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 30: 279-281, 1997.
28. Haviv YS, Safadi R. Normotensive renal crisis: Case report and review of the literature. Ren Fail 20: 733-736, 1998.
29. Anders HJ, Wiebecke B, Haedecke C, Sanden S, Combe C, Schlondorff D. MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease. Am J Kid Dis 33: E3, 1999.
30. Villaverde V, Balsa A, Cabezas JA, Fernandez-Prada M, Torre A, Mola EM. Normotensive renal failure in a patient with systemic sclerosis and a p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy. Rheumatology (Oxford) 38: 190-191, 1999.
31. Katrib A, Strugess A, Bertouch JV. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 19: 61-63, 1999.
32. Kohno K, Katayama T, Majima K, et al. A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment. Clin Nephrol 53: 479-482, 2000.
33. Maes B, Van Mieghem A, Messiaen T, Kuypers D, Van Damme B, Vanrenferghem Y. Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangitis type. Am J Kidney Dis 36: E16, 2000.
34. Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, Gur H. Pulmonary-renal syndrome in systemic sclerosis. Semin Arthritis Rheum 30: 403-410, 2001.